Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.
Dr. Dustin Portela on MSN2h
What You Need To Know Before Taking Ozempic - Doctor AnswersOzempic is a popular prescription medication for type 2 diabetes and weight loss. But before you start taking Ozempic, it's ...
A new weight loss injection called retatrutide has shown remarkable results in helping users shed weight quickly. However, ...
Demi Moore, Nicole Kidman and Mindy Kaling are among the stars who stepped out with slimmed-down figures during awards season, a trend that one expert says could be due to a "combination of factors." ...
The drugs have been hailed a monumental breakthrough in the war on obesity - but some users have reportedly suffered severe ...
Many people who have tried to lose weight by cutting calories are familiar with this frustrating reality: at some point, the body stops shedding ...
Kourtney Kardashian's ex, Scott Disick, admitted to using Mounjaro on a recent episode of The Kardashians which hit our ...
Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...
In recent years, the landscape of diabetes and weight management has been significantly altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists. These medications, initially developed ...
Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.
You've probably heard about the relatively new weight loss medications and the results some people have seen with them and you may have wondered if they could help you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results